porcin
reproduct
respiratori
syndrom
viru
prrsv
positivestrand
rna
viru
approxim
kb
length
belong
famili
arterivirida
prrsv
one
import
virus
hinder
develop
swine
industri
global
especi
emerg
highli
pathogen
prrsv
hpprrsv
recent
new
prrsv
mutant
strain
becom
pandem
china
name
prrsv
strain
genom
similar
strain
isol
us
prrsv
strain
featur
differ
recombin
produc
mani
mosaic
isol
enhanc
genet
divers
current
effect
method
control
viral
diseas
vaccin
antivir
agent
howev
vaccin
prrsv
infect
achiev
limit
success
primarili
due
high
genet
divers
viru
addit
genet
mutat
prrsv
genet
divers
also
gener
recombin
among
differ
strain
includ
vaccin
strain
importantli
commerci
vaccin
provid
complet
protect
heterolog
prrsv
infect
problem
outlin
indic
use
vaccin
may
ideal
strategi
prrsv
control
howev
explor
effect
antiprrsv
drug
may
overcom
issu
isobavachalcon
ibc
prenyl
chalcon
flavonoid
subclass
first
isol
psoralea
corylifolia
ibc
possess
wide
spectrum
biolog
activ
includ
antibacteri
antifung
anticanc
antireversetranscriptas
antitubercular
antioxid
function
howev
whether
ibc
potenti
antivir
activ
remain
unclear
current
studi
first
time
observ
ibc
antiprrsv
activ
furthermor
systemat
investig
demonstr
ibc
inhibit
prrsv
replic
postentri
stage
prrsv
infect
porcin
alveolar
macrophag
pam
obtain
lung
specificpathogenfre
spf
piglet
monkey
kidney
cell
cultur
dulbecco
modifi
eagl
medium
supplement
fetal
bovin
serum
fb
highli
pathogen
prrsv
strain
prrsv
strain
isol
lab
propag
titrat
cell
ibc
purchas
shanghai
tauto
biotech
compani
dissolv
ethanol
use
concentr
indic
cytotox
ibc
evalu
pam
cell
briefli
twofold
dilut
ibc
start
concentr
appli
confluent
cell
plate
incub
h
cytotox
ibc
evalu
use
cell
count
dojindo
laboratori
japan
accord
manufactur
protocol
defin
concentr
ibc
reduc
absorb
treat
cell
rel
cell
control
total
cell
plate
plate
h
later
cell
infect
multipl
infect
moi
h
next
cultur
medium
replac
differ
concentr
ibc
dilut
dmem
contain
fb
cell
harvest
indic
time
western
blot
immunofluoresc
analysi
total
rna
sampl
extract
use
rneasi
plu
mini
kit
qiagen
germani
total
rna
revers
transcrib
cdna
accord
manufactur
protocol
rt
reagent
kit
gdna
eras
takara
realtim
pcr
procedur
perform
use
agil
realtim
pcr
system
primer
probe
describ
previou
report
cell
infect
h
treat
variou
concentr
ibc
incub
indic
time
cell
fix
ethanol
permeabil
saponin
pb
block
bovin
serum
albumin
bsa
h
room
temperatur
rt
block
cell
incub
mous
antiprrsv
n
protein
monoclon
antibodi
made
lab
dilut
h
rt
dsrna
stain
mous
monoclon
antibodi
scicon
hungari
dilut
h
rt
wash
aliquot
fitclabel
antimous
igg
sigma
use
secondari
antibodi
nuclear
visual
cell
treat
dapi
sigma
immunofluoresc
observ
use
leica
tc
confoc
microscop
cell
wash
twice
pb
prepar
ripa
lysi
buffer
solarbio
cell
lysat
centrifug
rpm
min
supernat
collect
protein
concentr
determin
bca
assay
next
protein
sampl
separ
via
sodium
dodecyl
sulfat
polyacrylamid
gel
electrophoresi
sdspage
protein
band
transfer
onto
polypropylen
fluorid
pvdf
membran
membran
block
nonfat
milk
h
rt
incub
mous
antiprrsv
n
protein
monoclon
antibodi
made
laboratori
antibodi
sigma
h
rt
wash
three
time
pbst
tween
pb
membran
incub
h
hrpconjug
antimous
igg
antibodi
sigma
protein
band
visual
ecl
chemiluminesc
reagent
thermo
scientif
western
blot
band
quantifi
analyz
use
imagej
rel
intens
ratio
protein
band
n
calcul
indic
prrsv
replic
abil
valu
control
group
set
ibc
treat
group
normal
correspondingli
investig
antiprrsv
activ
ibc
drug
concentr
could
inhibit
prrsv
infect
approxim
inhibitori
concentr
determin
cell
infect
prrsv
moi
h
treat
twofold
dilut
ibc
total
rna
isol
cell
h
postinfect
pi
intracellular
prrsv
rna
copi
number
determin
rtpcr
percentag
inhibit
calcul
rna
copi
control
cell
rna
copi
cell
treat
ibc
rna
copi
control
indic
ibc
concentr
valu
control
group
set
ibctreat
group
normal
correspondingli
viru
attach
entri
assay
perform
preincub
cell
min
prrsv
moi
ibc
ad
cell
incub
addit
h
allow
attach
viru
cell
next
cell
wash
three
time
cold
pb
remov
unbound
viru
cell
collect
either
use
detect
prrsv
rna
level
via
realtim
pcr
assess
viral
attach
provid
fresh
medium
contain
ibc
incub
h
temperatur
shift
perform
promot
entri
viru
cell
incub
total
rna
collect
analyz
realtim
pcr
assess
viral
entri
cell
infect
prrsv
moi
incub
cell
wash
three
time
pb
remov
unbound
virus
replenish
fb
postinfect
inhibit
studi
cell
replenish
fb
supplement
ibc
specif
time
point
h
cell
harvest
h
ibc
treatment
level
prrsv
replic
estim
western
blot
analysi
origin
softwar
use
graphic
represent
calcul
use
nonlinear
regress
statist
signific
establish
use
independ
ttest
pvalu
less
consid
signific
structur
ibc
shown
figur
assess
antiprrsv
activ
ibc
first
evalu
cytotox
ibc
cell
fig
pam
cell
fig
result
indic
cell
viabil
significantli
affect
ibc
concentr
ibc
cell
data
show
cytotox
effect
ibc
solvent
alcohol
also
evalu
result
indic
alcohol
effect
cell
fig
pam
cell
fig
next
evalu
antiprrsv
capabl
ibc
cell
infect
prrsv
moi
treat
differ
concentr
ibc
first
determin
progeni
viru
titer
found
ibc
significantli
inhibit
prrsv
replic
dosedepend
manner
fig
confirm
find
also
perform
indirect
immunofluoresc
assay
stain
cell
prrsv
n
protein
antibodi
observ
prrsv
replic
fluoresc
microscopi
shown
figur
prrsv
replic
significantli
block
ibc
western
blot
analysi
reveal
prrsv
n
protein
level
decreas
markedli
indic
increas
concentr
ibc
significantli
inhibit
prrsv
replic
fig
determin
whether
inhibit
strain
specif
addit
assay
current
pandem
strain
isol
lab
observ
also
inhibit
ibc
fig
thu
data
indic
ibc
inhibit
prrsv
strain
specif
furthermor
antivir
activ
ibc
prrsv
dose
depend
success
fig
select
index
si
ratio
despit
evid
ibc
inhibit
prrsv
replic
viral
stage
influenc
ibc
remain
unknown
determin
step
viral
life
cycl
affect
ibc
first
perform
timeofdrugaddit
assay
result
indic
ibc
markedli
inhibit
prrsv
ad
earli
infect
remain
inhibitori
ad
h
pi
wherea
prrsv
inhibit
limit
ibc
ad
late
h
pi
fig
data
suggest
ibc
target
earli
phase
viral
life
cycl
abl
prevent
viral
infect
viru
enter
postrepl
stage
infect
next
test
whether
ibc
inhibit
prrsv
disturb
prrsv
attach
entri
result
demonstr
prrsv
attach
influenc
ibc
fig
interestingli
prrsv
entri
assay
result
attach
assay
demonstr
neither
prrsv
attach
entri
influenc
ibc
fig
addit
ibc
inhibitori
h
pi
wherea
effect
prrsv
attach
entri
fig
b
inhibit
postentri
stage
led
us
specul
ibc
inhibit
prrsv
replic
stage
viral
rna
synthesi
test
whether
ibc
block
viral
rna
replic
perform
inhibit
experi
use
pam
cell
stain
dsrna
intermedi
viral
replic
antibodi
recogn
dsrna
result
indic
dsrna
level
significantli
decreas
ibctreat
cell
fig
b
data
clearli
suggest
ibc
block
earli
stage
viral
life
cycl
like
initi
viral
rna
replic
current
prrsv
signific
problem
swine
industri
china
verit
pandora
box
chines
pig
industri
first
outbreak
current
pandem
strain
highli
divers
commerci
vaccin
provid
partial
protect
strain
thu
antiprrsv
drug
may
suitabl
prrsv
control
futur
tradit
chines
medicin
tcm
wide
use
sourc
novel
drug
mani
crude
tcm
herbal
extract
shown
inhibit
prrsv
replic
ibc
extract
p
corylifolia
use
tcm
cheng
et
al
systemat
analyz
seventeen
compound
deriv
tcm
test
prrsv
antivir
activ
vitro
two
compound
chlorogen
acid
scutellarin
shown
great
antiprrsv
replic
potenti
studi
inhibit
ratio
chlorogen
acid
scutellarin
reach
respect
maximum
noncytotox
concentr
contrast
ibc
inhibit
ratio
exceed
improv
maximum
noncytotox
concentr
test
compound
result
indic
ibc
effect
chlorogen
acid
scutellarin
ibc
multipl
biolog
activ
potent
abrog
akt
erk
signal
pathway
exert
antiprolif
effect
sever
human
cancer
cell
line
also
induc
apoptosi
associ
mitochondri
pathway
akt
report
play
posit
role
prrsv
gene
express
entri
prrsv
replic
may
depend
activ
erk
signal
pathway
demonstr
play
import
role
postentri
step
prrsv
replic
cycl
enhanc
prrsv
infect
erk
pathway
may
also
contribut
hpprrsv
pathogenesi
apoptosi
also
influenc
prrsv
replic
sinc
induct
apoptosi
cell
increas
viru
replic
ibc
inhibit
prrsv
replic
may
occur
modul
abovement
pathway
ibc
may
applic
efficaci
safe
drug
treatment
cancer
neuroblastoma
ibc
report
inhibit
sarscov
papainlik
proteas
howev
whether
ibc
inhibit
infecti
viru
test
studi
studi
first
report
ibc
potent
antivir
activ
demonstr
block
prrsv
replic
initi
viral
rna
replic
vitro
howev
unansw
question
explor
futur
first
whether
ibc
also
show
antiprrsv
activ
vivo
must
investig
second
blockag
viral
rna
format
direct
indirect
effect
third
virus
also
inhibit
ibc
conclus
evalu
whether
ibc
antivir
potenti
prrsv
infect
treatment
vitro
studi
establish
ibc
effici
inhibit
replic
hpprrsv
current
chines
epidem
strain
without
signific
drug
toxic
thu
ibc
may
candid
evalu
therapeut
agent
prrsv
infect
swine
vivo
